[extropy-chat] QALY pharmacoeconomics]

Lifespan Pharma/Morris Johnson CTO megao at sasktel.net
Sun Dec 18 23:39:04 UTC 2005



-------- Original Message --------
Subject: 	QALY pharmacoeconomics
Date: 	Sun, 18 Dec 2005 17:37:32 -0600
From: 	Lifespan Pharma/Morris Johnson CTO <megao at sasktel.net>
To: 	Marc Paquette <paquettemarc at yahoo.com>, "Barb St.Jean" 
<editor at cannabishealth.com>, Brian Taylor <bct at sunshinecable.com>, 
Alison Myrden <alisonmyrden at yahoo.ca>, Lynne Belle-Isle 
<LynneB at cdnaids.ca>, bernhard.juurlink at usask.ca, Noreen Evers 
<willwrld at telus.net>, maxcorn63 <maxcorn63 at yahoo.ca>, ocma-bamc 
<ocma-bamc at hc-sc.gc.ca>, valerie_lasher at hc-sc.gc.ca, 
medusers at yahoogroups.com, medpot-discuss at yahoogroups.com, ExI chat list 
<extropy-chat at lists.extropy.org>, futuretag at yahoogroups.com, Morris 
Johnson <mfj.eav at gmail.com>, John Turmel <turmel at ncf.ca>



Questions  I'd like to pose for discussion:

How to determine  QALY (Quality Adjusted Life Year)  values  for  
preventative medical use of natural health products.
Is there any published work to use?

How to compare these  to known QALY   values for  crisis managment 
treatment measures which are used once a condition
develops.

This would be complicated by the comparison of 2 separate age groups and 
health states (young and healthy  for preventative, aged and disease 
prone or with active disease for crisis management)  and the uncertainty 
of whether
a predicted  future cost would happen , which future cost to compare to 
or how to justify using  a specific future cost to compare with.

Health care rationing can be in the form of waiting times during which 
future disease progresses from very long term  X moderate cost  , easily 
treatable OR  more
costly crisis X  long term continued  management  OR  less total cost , 
high cost  short term  palliative end-stage care.

Without such cost estimates public funders can argue they lack 
information to  make decisions to cover or refuse to cover dietary or 
nutraceutical preventative health care measures.
Also of note is the contention that authorities sometimes  try to 
dissallow access by regulatory or liability means  to those willing to 
pay personally
for experimental or unproven unconventional drugs or treatments.

If a public system refuses to pay and the individual pays  can the 
public system interfere with a market driven
exchange of services or products between a willing buyer and a willing 
seller?
The rights of the patient to determine what measures they wish are the 
exact opposite of the patient's right to decline
treament or even intentionally undertake measures to damage theit health 
status.  If living wills and refusal of treatment
are not a crime how can the exact opposite be denied or abstructed by 
regulators and lawmakers?

For example:
A patient who is extremely wealthy (say billionaire Ray Kurzeil or Bill 
Gates) decides that after 20 years of smoking (a ficticious statement in 
the case of the 2 named individuals)  to have extensive body scans done.
He pays to have these on demand by leasing  his own MRI.
He then hires  a clinic and doctor (by bringing to to North America a 
doctor from  a chinese hospital where these procedures are a practice) 
to  privately to inject liquid nitrogen into precancerous lung tissue to 
prevent future cancer.
He pays an herbalist practitioner to formulate and compound  for 
consumption numerous herbals and off-lable Rx medications  to regenerate 
damaged tissues. 
He then finishes  by renting a hyperbaric diving decompression chamber 
(hyperbaric hydrogen therapy) for a month to
scavange any missed cancer or pre-cancer.

It is given in this case that a person like Ray Kurzweil who is a 
billionaire who already spends well over a million dollars a year to 
prevent diseases
and aging processes he only knows might be statisically possible if 
faced by the above history would  not balk over the
4-10 million dollar personal expenditure of tax paid dollars over a year 
to carry out the above.

Would authorities use numerous regulatory and other legal means to deny 
access to someone who demands to
not be interfered with as he directs and pays for all these activities 
and services?

I am posing  the case that not only might health care be rationed by 
denial of already available conventional services
but might also be denied by indirect means.
In the context of the attached thesis can a free society act to deny the 
above health care personal actions without
infringing on the constitutional rights of the citizen to own and 
control their body just like any other piece of personal property
under the Property Rights provision of the Charter Of Rights?

The attachment, a 100 page  thesis is forwarded  by separate message as 
it may not pass the spam/file-size or other filters of some of you.

Morris Johnson
mfj.eav at gmail.com
306-447-4944
Box 10 Beaubier, Sk. Canada
S0C-0H0











-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20051218/00d8d7cc/attachment.html>


More information about the extropy-chat mailing list